CIK: 0001910264
Total reported value
$915.4M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ZBIO | Zenas Biopharma INC | Stock-Other | 25.90% | -15.14% | +2.57% | |
| 2 | ACLXGBX | Arcellx INC | Stock-Other | 21.66% | +7.77% | — | |
| 3 | CRSP | CRISPR Therapeutics AG | Stock-Healthcare | 15.14% | -4.55% | — | |
| 4 | DSGN | Design Therapeutics INC | Stock-Other | 8.67% | -1.08% | — | |
| 5 | MLYS | Mineralys Therapeutics INC | Stock-Other | 8.03% | -3.40% | -26.02% | |
| 6 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 6.62% | -3.10% | — | |
| 7 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 5.34% | +1.05% | — | |
| 8 | ALMS | Alumis INC | Stock-Other | 2.71% | +2.01% | — | |
| 9 | ORKA | Oruka Therapeutics INC | Stock-Other | 1.85% | +0.46% | — | |
| 10 | OCS | Oculis Holding AG | Stock-Other | 1.81% | +0.05% | +98.77% | |
| 11 | ✓ | Engene Holdings INC | Stock-Other | 0.96% | -0.40% | — | |
| 12 | NKTX | Nkarta INC | Stock-Other | 0.87% | -0.10% | — | |
| 13 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 0.45% | -0.13% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ZBIO | Zenas Biopharma INC | +10.1% | +2.57% | Add |
| 2 | ALMS | Alumis INC | +1.6% | — | Unchanged |
| 3 | DSGN | Design Therapeutics INC | +1.6% | — | Unchanged |
| 4 | OCS | Oculis Holding AG | +1% | +98.77% | Add |
| 5 | SPRY | Ars Pharmaceuticals INC | +0.8% | — | Unchanged |
| 6 | ORKA | Oruka Therapeutics INC | +0.7% | — | Unchanged |
| 7 | ✓ | Engene Holdings INC | +0.2% | — | Unchanged |
| 8 | NKTX | Nkarta INC | -0.1% | — | Unchanged |
| 9 | ORIC | Oric Pharmaceuticals INC | -2.5% | — | Unchanged |
| 10 | MLYS | Mineralys Therapeutics INC | -3.6% | -26.02% | Trim |
| 11 | CRSP | CRISPR Therapeutics AG | -4% | — | Unchanged |
| 12 | ACLXGBX | Arcellx INC | -6.2% | — | Unchanged |
| 13 | RARE | Ultragenyx Pharmaceutical In | — | NEW | New buy |